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In vitro, brain-derived endothelium loses
several blood-brain barrier (BBB) charac-
teristics such as -glutamyl transpeptidase, tight
junctions and the polarized transport of amino
acids. However, these features are regained
during co-culture with astroglial cells or their
conditioned medium. To determine if similar
BBB deficits would occur in situ when micro-
vessels were denuded of their astrocytic
complement, chronic and acute perivascular
astroglial destruction was effected by
subcutaneous injection of the gliotoxin 6-
aminonieotinamide (6-AN) into neonatal and
adult Wistar rats. Animals bearing neocortical
transplants were also exposed to the toxin to test
whether glial and/or barrier defects would occur
within the grafts. 6-AN is a nicotinamide
antagonist which causes a blockade of the
pentose-phosphate pathway. Both astrocytes
and oligodendrocytes are particularly susceptible
to this toxin at the dosages used in this study (10
mg/kg body weight), and they subsequently
undergo cytotoxic edema followed by degener-
ation. The mierovascular endothelium sustains
no morphological damage after 6-AN
administration.
Neonatal animals received 4 intraperitoneal
injections of 6-AN during the first postnatal
week and were sacrificed at ages ranging from 6
12 days. Age-matched controls received injec-
tions of saline. 6-AN caused necrosis of glial cells
throughout the entire CNS in neonates resulting
in the appearance of spongy degeneration in
both white and gray matter. Perivascular astro-
glial processes were immensely swollen, with
degenerating organelles and plasma mem-
branes. The perivascular basement membrane
appeared to be intact and stained normally with
anti-laminin. Immunostaining for the glucose
transporter protein and histochemical staining
for -glutamyl transpeptidase revealed an
expression of both BBB markers throughout the
CNS of the experimental animals which was
comparable to that of the age-matched controls.
The BBB to endogenous protein remained
intact as shown by immunostaining with rat
serum albumin (RSA). Similarly, intravascularly
injected horseradish peroxidase (HRP) did not
leak from the microvasculature of experimental
animals except in normally permeable areas and
ultrastructural examination of these animals
revealed a normal endocytotic uptake of HRP.
Thus, despite widespread glial destruction
throughout the neonatal CNS, the BBB
characteristics of the developing vasculature
were unaffected.
Adult rats received a single intraperitoneal
injection of 6-AN and were sacrificed after 1 5
days. Although mature rats exhibited glial
necrosis only in specific regions of spinal cord,
medulla, cerebellum and thalamus, the micro-
vascular ultrastructure of the affected regions
was similar to that of 6-AN-exposed neonates.
Petechial hemorrhages associated with veins
were observed within the lesioned areas.
Perivascular laminin immunoreactivity appeared
to be normal. Endothelial immunoreactivity for
the glucose transporter and. the endothelial
barrier antigen, an as yet uncharacterized BBB
marker, also remained at normal levels. How-
ever, serum albumin extravasation was apparent
in the affected CNS regions, and small areas of
HRP leakage were also present, indicating that a
breach of the BBB had occurred. Ultrastructural
examination of the HRP leaks indicated that
there was no increase in vesicular transport nor
was there a conduit through the tight junctional
complexes, thus allowing the conclusion that the
observed protein leakage was the result of the
venous hemorrhages observed within the
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affected CNS regions.
E19 fetal neocortex was transplanted to
either the fourth ventricle or the parietal cortex
of adult hosts. The animals received 6-AN
injections at one week or one month post-
operative and were sacrificed two days later.
One week old transplants in either location were
well vascularized and contained few degener-
ating glial cells when compared to the neocortex
of 7-8 day old rat pups given a similar dosage of
the gliotoxin. Glial cells within one month old
transplants appeared completely intact and no
BBB abnormalities were detected, although
some reactive astroglia at the intraparenchymal
interface region were damaged by 6-AN.
These results suggest that the induction and
maintenance of some BBB properties in situ
may not be completely dependent on astroglial
contact as they are in vitro. However, because
the microvascular basement membrane remains
intact, the possibility that factors secreted by
astrocytes may still reside there to maintain
endothelial barrier properties cannot be ruled
out.
Glial cells within neocortical transplants do
not appear to be as susceptible to the effects of
6-AN as comparably aged neocortex in situ. This
phenomenon may be the result of a change in
glial cell metabolism within transplanted
neocortex which may have significance in terms
of their interactions with adjacent neurons.